Uloric

If you or someone you love was harmed by a defective pharmaceutical or over-the-counter medication, contact the team at Fulmer Sill right away.

Oklahoma City Uloric Attorneys

Uloric® (Febuxostat) is a medication used to treat gout, which is a debilitating type of arthritis that occurs when uric acid builds up in the blood and causes inflammation in the joints. Uloric treats gout by inhibiting the enzyme xanthine oxidase, which reduces the amount of uric acid in the body. Uloric is manufactured by Takeda Pharmaceuticals, a Japanese-based pharmaceutical company. When it was approved by the FDA in 2009, it was the first new gout drug in over 40 years.

FDA Warnings & Precautions for Uloric

In November 2012, the U.S. Food and Drug Administration (FDA) published a safety warning about cases of fatal and non-fatal liver failure in patients on Uloric. During clinical trials, 6.6% of Uloric patients developed abnormal liver function, and 2% developed liver enzyme levels greater than three times the upper limit of normal, which is a symptom of liver damage. The FDA recommends liver tests in patients who have symptoms of liver damage, including abdominal pain, loss of appetite, fatigue, dark urine, and jaundice (yellowing of skin, eyes).

Additional FDA warnings and precautions related to Uloric use include:

  • Nausea
  • Liver failure
  • Kidney damage
  • Rhabdomyolysis
  • Heart attack
  • Stroke
  • Rash
  • Immune system disorders
  • Allergic reaction (anaphylaxis, rash, Stevens Johnson syndrome)
  • Psychiatric disorders (psychotic behavior, aggressive thoughts)
  • Kidney and urinary disorders
  • Bone marrow failure
  • Severe bleeding

Uloric & Risk of Heart-Related Death

FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of heart-related death with febuxostat (Uloric) compared to another gout medicine called allopurinol. FDA required the Uloric drug manufacturer, Takeda Pharmaceuticals, to conduct this safety study when the medicine was approved in 2009. The febuxostat drug labels already carry a warning about cardiovascular events because the clinical trials conducted before approval showed a higher rate of heart-related problems in patients treated with febuxostat compared to allopurinol. These problems included heart attacks, strokes, and heart-related deaths. As a result, the FDA required an additional safety clinical trial after the drug was approved and on the market to better understand these differences, and that trial was finished.

The safety trial was conducted in over 6,000 patients with gout, treated with either febuxostat or allopurinol. The primary outcome was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of inadequate blood supply to the heart requiring urgent surgery. The preliminary results show that overall, febuxostat did not increase the risk of these combined events compared to allopurinol. However, when the outcomes were evaluated separately, febuxostat showed an increased risk of heart-related deaths and death from all causes.

Uloric & Rhabdomyolysis

Rhabdomyolysis, one of the most serious side effects to be linked to Uloric, is a potentially fatal condition that occurs when muscle fibers break down in the body and release myoglobin into the blood. Myoglobin is a protien that can clog the kidneys and affect their ability to function normally. The symptoms of rhabdomyolysis may be difficult to identify because the disease manifests differently from patient to patient.

When they do present, however, symptoms of rhabdomyolysis typically include varying degrees of:

  • Abnormal urine color (dark, red, cola-colored)
  • Decreased urine production
  • General weakness
  • Muscle stiffness or aching (myalgia)
  • Muscle tenderness
  • Weakness of the affected muscles

Please contact Fulmer Sill at (405) 433-7414 for a free consultation. Hablamos español.

Do You Have Questions About Injuries Related to Uloric?

If you or a loved one have been affected by the drug Uloric, we encourage you to consult with our team as soon as possible. With our extensive knowledge and expertise, you can rest assured that you will have legal representation you can trust. All initial consultations are free, and we don’t charge any up-front fees for representation. We handle all fees on a contingency basis, meaning that unless we’re successful, you don’t have to pay us.

Big Cases Without Big Egos

You can rely on our tenacious and hardworking team to fight tirelessly for every penny you are owed.

    I felt taken care of by these highly skilled and intelligent attorneys.

    “From the first meeting to the last meeting I felt taken care of by these highly skilled and intelligent attorneys.”

    - Quinda B.
    Totally, "two thumbs up"!

    “They LISTENED to me... they were interested in what I had to say. I would definitely recommend them to anyone having problems with their insurance company. Can't say enough positive things about all who work there.”

    - Angie P.
    The settlement was beyond expectations.

    “Simone is known as an expert in this type of litigation. From the get-go, it was obvious her knowledge and experience was going to be beneficial. A tentative agreement was reached before the day was over and a final agreement a week later.”

    - Todd W.
    Chad, Lauren & Ashley were an outstanding team.

    “Their professionalism & diligence was superior only to be equaled by their compassion, understanding, and friendliness. Their communications with keeping me informed of the progress of the case were timely & informative.”

    - Bill I.
    I love working with Fulmer Sill!

    “They were very helpful, kind, and patient. And I was thankful for their negotiation skills and how they understood how important I am as a human being therefore the finishing results turn out to be more than I expected.”

    - Jasmine N.

Work With Fulmer Sill

Different Approach, Same Values
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
    • By providing your phone number, you agree to receive text messages from Fulmer Sill. Message and data rates may apply. Message frequency varies.

    Must agree to terms.